The Epoch Times
The Epoch Times
Focus

AbbVie

Companies
Companies
|
Ryan Morgan

Top 5 US Pharma Companies Netted $82 Billion in 2022: Report

Jul 25, 2023
|
Ryan Morgan
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
Jul 25
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
The Epoch Times
|
Reuters

Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion

Nov 16, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion
Nov 16
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
Companies
|
Reuters

US FDA Declines to Approve Revance’s Frown-Line Treatment

Oct 18, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US FDA Declines to Approve Revance’s Frown-Line Treatment
Oct 18
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
Companies
|
Ryan Morgan

Top 5 US Pharma Companies Netted $82 Billion in 2022: Report

Jul 25, 2023
|
Ryan Morgan
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
Jul 25
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
The Epoch Times
|
Reuters

Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion

Nov 16, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion
Nov 16
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
Companies
|
Reuters

US FDA Declines to Approve Revance’s Frown-Line Treatment

Oct 18, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US FDA Declines to Approve Revance’s Frown-Line Treatment
Oct 18
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.